Treatment of fibromyalgia syndrome with Super Malic®: A randomized, double blind, placebo controlled, crossover pilot study

Medicine and Dentistry

• Amaurosis 16%
• Combination Therapy 16%
• Drug Therapy 16%
• Fibromyalgia 66%
• Low Drug Dose 16%
• Malic Acid 16%
• Open-Label Trial 16%
• Pain 33%
• Patient 33%
• Placebo 66%
• Placebo-Controlled Study 16%
• Therapeutic Procedure 100%
• Treatment Duration 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Blindness 16%
• Fibromyalgia 66%
• Magnesium 16%
• Malic Acid 16%
• Open-Label Trial 16%
• Pain 33%
• Placebo-Controlled Study 16%
• Syndrome 66%
• Tablet 66%